A Clinical Observation of the Intravesical Thiotepa in Bladder Cancer.
- Author:
Keun Sik MIN
1
;
Kyu Hong PARK
Author Information
1. Department of Urology, National Medical Center, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Intravesical chemotherapy;
thiotepa;
bladder cancer
- MeSH:
Carcinoma, Transitional Cell;
Follow-Up Studies;
Leukopenia;
Thiotepa*;
Urinary Bladder Neoplasms*;
Urinary Bladder*
- From:Korean Journal of Urology
1981;22(2):195-199
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Primary transitional cell carcinoma of the bladder was treated with prophylactic and therapeutic Intravesical thiotepa in 7 cases. In 5 cases of stage A tumor, postoperative follow up was averaged 10.8 months and 4 cases were tumor free (80%). In 2 cases of infiltrating tumor, the instillation was not effective. Thiotepa can be given safely in the 7 days post-operative period and no leukopenia and bladder irritation symptoms were occurred.
